Abbott's Affordable BinaxNOW^™ COVID-19 Antigen Test Receives FDA Authorization Posted: Aug 31, 2020 Studies Say Abbott's  ID NOW™ COVID-19 Test Works Best at Acute Stage of Infection Posted: May 29, 2020 Abbott Agrees With FDA To Perform Post-Market Study on Questionable COVID-19 Test Posted: May 18, 2020 Abbott ID NOW™ COVID-19 Instructions Modified Due to Reported False-Negatives Posted: Apr 24, 2020 Instant Results from Abbott's COVID-19 Point-of-Care Test Posted: Mar 30, 2020 Abbott Receives CE Mark for Alinity™ m Molecular Diagnostics System and Assays Posted: Mar 26, 2019 CE Mark for Determine™ HBsAg 2 - Sensitive Lateral Flow for Hepatitis B Surface Antigen Posted: Feb 25, 2019 Abbott Acquires Alere to Become POC Diagnostics Market Leader Posted: Feb 09, 2016 CE Marking for Abbott's IRIDICA Infectious Disease Platform Posted: Dec 15, 2014 IRIDICA Identifies Directly from Specimen in 8 Hours Posted: Sep 15, 2014